amlodipine has been researched along with digoxin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schwartz, JB | 1 |
| Abernethy, DR | 1 |
| Struthers, AD | 1 |
| Bondioli, A; Calabresi, L; De Rosa, C; Ferrara, S; Mombelli, G; Pazzucconi, F; Sirtori, CR; Yeates, R; Zoppi, F | 1 |
| Higashide, T; Kakihara, M; Mizumura, T; Ogata, I; Okai, T; Oshima, A; Sugimura, Y; Tamamura, T; Tonoike, N; Yoshida, S | 1 |
| Dunnington, GH; Johri, S; Vnencak-Jones, CL | 1 |
| Del Giaccio, A; Eblen-Zajjur, A | 1 |
| Baig, AM; Iqbal, J; Khan, NA | 1 |
| Baig, AM; Khan, NA; Kulsoom, H; Siddiqui, R | 1 |
| Borek-Dohalska, L; Fojtikova, V; Martinkova, M; Mináriková, M; Sedláček, J; Šikut, M; Stiborová, M; Vyskočilová, E | 1 |
| Irie, S; Ishizuka, H; Ishizuka, T; Kato, M; Kirigaya, Y; Nakatsu, T; Nishikawa, Y; Shimizu, T; Shiramoto, M; Uchimaru, H | 1 |
3 review(s) available for amlodipine and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The pharmacokinetic profile of amlodipine.
Topics: Administration, Oral; Aging; Amlodipine; Angina Pectoris; Animals; Biological Availability; Calcium Channel Blockers; Cimetidine; Digoxin; Drug Interactions; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Liver Cirrhosis; Nifedipine | 1989 |
Rationalizing the heart failure trials: from theory to practice.
Topics: Adrenergic beta-Antagonists; Amiodarone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Blood Pressure; Clinical Trials as Topic; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Treatment Outcome; Vasodilator Agents | 1997 |
3 trial(s) available for amlodipine and digoxin
| Article | Year |
|---|---|
Effects of amlodipine on steady-state digoxin concentrations and renal digoxin clearance.
Topics: Adult; Amlodipine; Blood Pressure; Calcium Channel Blockers; Digoxin; Drug Interactions; Electrocardiography; Humans; Kidney; Male; Nifedipine | 1988 |
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Female; Humans; Male; Middle Aged; Nociceptors; Pindolol; Propranolol; Young Adult | 2010 |
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects.
Topics: Adult; Amlodipine; Antihypertensive Agents; Asian People; Calcium Channel Blockers; Cross-Over Studies; Digoxin; Drug Interactions; Healthy Volunteers; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pyrroles; Sulfones; Young Adult | 2020 |
15 other study(ies) available for amlodipine and digoxin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a model based on body composition to predict drug kinetics-1 evaluation in healthy volunteers.
Topics: Adult; Aged; Algorithms; Amlodipine; Anesthetics, Local; Anti-Bacterial Agents; Antihypertensive Agents; Area Under Curve; Body Composition; Body Water; Cardiotonic Agents; Digoxin; Electric Impedance; Half-Life; Humans; Intracellular Fluid; Lidocaine; Models, Biological; Pharmacokinetics; Tobramycin | 2004 |
[Basedow disease with recurrent syncopal attack and severe pulmonary hypertension].
Topics: Aged; Amlodipine; Atrial Fibrillation; Digoxin; Female; Graves Disease; Humans; Hypertension, Pulmonary; Methimazole; Recurrence; Syncope; Treatment Outcome; Vertigo | 2007 |
A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.
Topics: Aged, 80 and over; Amlodipine; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Digoxin; Dyspnea; Humans; Hypertension, Pulmonary; Male; Pulmonary Artery; Sulfonamides; Warfarin | 2010 |
In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.
Topics: Acanthamoeba castellanii; Amlodipine; Antiprotozoal Agents; Culture Media; Digoxin; Drug Evaluation, Preclinical; Genotype; Haloperidol; Loperamide; Parasitic Sensitivity Tests; Prochlorperazine; Trophozoites | 2013 |
Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amiodarone; Amlodipine; Apomorphine; Balamuthia mandrillaris; Brain; Cells, Cultured; Digoxin; Drug Synergism; Drug Therapy, Combination; Encephalitis; Endothelial Cells; Haloperidol; Humans; Loperamide; Microvessels; Prochlorperazine; Procyclidine | 2014 |
The capacity and effectiveness of diosmectite and charcoal in trapping the compounds causing the most frequent intoxications in acute medicine: A comparative study.
Topics: Adsorption; Alpha-Amanitin; Amlodipine; Antidotes; Aspirin; Carbamazepine; Charcoal; Digoxin; Ibuprofen; Imipramine; Oxazepam; Phenobarbital; Poisoning; Promethazine; Silicates; Theophylline | 2017 |